"Lymphoma, Follicular" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Malignant lymphoma in which the lymphomatous cells are clustered into identifiable nodules within the LYMPH NODES. The nodules resemble to some extent the GERMINAL CENTER of lymph node follicles and most likely represent neoplastic proliferation of lymph node-derived follicular center B-LYMPHOCYTES.
MeSH Number(s)
C04.557.386.480.350
C15.604.515.569.480.350
C20.683.515.761.480.350
Concept/Terms
Lymphoma, Follicular- Lymphoma, Follicular
- Follicular Lymphomas
- Lymphomas, Follicular
- Follicular Lymphoma
- Lymphoma, Nodular
- Lymphomas, Nodular
- Nodular Lymphoma
- Nodular Lymphomas
- Giant Follicular Lymphoma
- Lymphoma, Giant Follicular
- Brill-Symmers Disease
- Brill Symmers Disease
- Disease, Brill-Symmers
- Follicular Lymphoma, Giant
- Follicular Lymphomas, Giant
- Giant Follicular Lymphomas
- Lymphomas, Giant Follicular
Lymphoma, Small Cleaved-Cell, Follicular- Lymphoma, Small Cleaved-Cell, Follicular
- Lymphocytic Lymphoma, Nodular, Poorly-Differentiated
- Lymphoma, Lymphocytic, Nodular, Poorly Differentiated
- Small Follicular Center-Cell Lymphoma
- Small Follicular Center Cell Lymphoma
- Lymphoma, Small Cleaved Cell, Follicular
- Lymphoma, Small Follicular Center-Cell
- Lymphoma, Small Follicular Center Cell
- Lymphoma, Small Lymphoid, Follicular
- Small Cleaved-Cell Lymphoma, Follicular
- Small Cleaved Cell Lymphoma, Follicular
- Lymphocytic Lymphoma, Nodular, Poorly Differentiated
- Lymphoma, Lymphocytic, Nodular, Poorly-Differentiated
Lymphoma, Large-Cell, Follicular- Lymphoma, Large-Cell, Follicular
- Large-Cell Lymphoma, Follicular
- Large Cell Lymphoma, Follicular
- Lymphoma, Follicular Large-Cell
- Lymphoma, Follicular Large Cell
- Lymphoma, Histiocytic, Nodular
- Lymphoma, Large Cell, Follicular
- Histiocytic Lymphoma, Nodular
- Histiocytic Lymphomas, Nodular
- Lymphoma, Nodular Histiocytic
- Lymphomas, Nodular Histiocytic
- Nodular Histiocytic Lymphoma
- Nodular Histiocytic Lymphomas
- Lymphoma, Nodular, Large Follicular Center Cell
- Lymphoma, Nodular, Large Follicular Center-Cell
- Nodular Large Follicular Center-Cell Lymphoma
- Nodular Large Follicular Center Cell Lymphoma
- Follicular Large-Cell Lymphoma
- Follicular Large Cell Lymphoma
- Follicular Large-Cell Lymphomas
- Large-Cell Lymphomas, Follicular
- Lymphomas, Follicular Large-Cell
- Large Lymphoid Lymphoma, Nodular
- Lymphoma, Large Lymphoid, Nodular
Lymphoma, Mixed-Cell, Follicular- Lymphoma, Mixed-Cell, Follicular
- Lymphoma, Follicular, Mixed Cell
- Lymphoma, Follicular, Small and Large Cleaved-Cell
- Lymphoma, Follicular, Mixed Lymphocytic-Histiocytic
- Mixed-Cell Lymphoma, Follicular
- Mixed Cell Lymphoma, Follicular
- Lymphoma, Follicular, Small and Large Cleaved Cell
- Lymphoma, Nodular, Mixed Lymphocytic Histiocytic
- Lymphoma, Nodular, Mixed Lymphocytic-Histiocytic
- Lymphoma, Nodular, Mixed Small and Large Cell
- Follicular Mixed-Cell Lymphoma
- Follicular Mixed Cell Lymphoma
- Follicular Mixed-Cell Lymphomas
- Lymphoma, Follicular Mixed-Cell
- Lymphomas, Follicular Mixed-Cell
- Mixed-Cell Lymphomas, Follicular
- Lymphoma, Follicular, Mixed Small and Large Lymphoid
Below are MeSH descriptors whose meaning is more general than "Lymphoma, Follicular".
Below are MeSH descriptors whose meaning is more specific than "Lymphoma, Follicular".
This graph shows the total number of publications written about "Lymphoma, Follicular" by people in Harvard Catalyst Profiles by year, and whether "Lymphoma, Follicular" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1993 | 2 | 0 | 2 |
1994 | 2 | 2 | 4 |
1995 | 1 | 1 | 2 |
1996 | 2 | 1 | 3 |
1997 | 4 | 1 | 5 |
1998 | 6 | 0 | 6 |
1999 | 6 | 2 | 8 |
2000 | 1 | 2 | 3 |
2001 | 3 | 0 | 3 |
2002 | 8 | 2 | 10 |
2003 | 3 | 1 | 4 |
2004 | 2 | 1 | 3 |
2005 | 7 | 4 | 11 |
2006 | 4 | 0 | 4 |
2007 | 4 | 0 | 4 |
2008 | 1 | 2 | 3 |
2009 | 7 | 0 | 7 |
2010 | 3 | 1 | 4 |
2011 | 10 | 1 | 11 |
2012 | 5 | 2 | 7 |
2013 | 13 | 2 | 15 |
2014 | 16 | 2 | 18 |
2015 | 12 | 3 | 15 |
2016 | 9 | 1 | 10 |
2017 | 8 | 0 | 8 |
2018 | 8 | 2 | 10 |
2019 | 5 | 0 | 5 |
2020 | 8 | 0 | 8 |
2021 | 10 | 1 | 11 |
2022 | 18 | 0 | 18 |
Below are the most recent publications written about "Lymphoma, Follicular" by people in Profiles.
-
Diagnostic Discrepancies in Small-volume Biopsy for the Initial Diagnosis, Recurrence, and Transformation of Follicular Lymphoma: A Multi-Institutional Collaborative Study. Am J Surg Pathol. 2023 Feb 01; 47(2):212-217.
-
Follicular lymphoma: 2023 update on diagnosis and management. Am J Hematol. 2022 Dec; 97(12):1638-1651.
-
UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial. Lancet Haematol. 2022 Nov; 9(11):e833-e843.
-
Circulating immune markers and risks of non-Hodgkin lymphoma subtypes: A pooled analysis. Int J Cancer. 2023 Mar 01; 152(5):865-878.
-
MCL-133 Pirtobrutinib, a Highly Selective, Non-Covalent (Reversible) BTK Inhibitor in Previously Treated Mantle Cell Lymphoma: Updated Results From the Phase 1/2 BRUIN Study. Clin Lymphoma Myeloma Leuk. 2022 Oct; 22 Suppl 2:S394-S395.
-
Disease-Defining Molecular Features of Primary Cutaneous B-Cell Lymphomas: Implications for Classification and Treatment. J Invest Dermatol. 2023 Feb; 143(2):189-196.
-
Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma. Blood. 2022 08 25; 140(8):851-860.
-
Current Considerations in the Treatment of Grade 3 Gliomas. Curr Treat Options Oncol. 2022 09; 23(9):1219-1232.
-
Serum high-density lipoprotein cholesterol level has a significant prognostic impact on outcomes of follicular lymphoma patients. Medicine (Baltimore). 2022 Jul 29; 101(30):e29541.
-
Complete responses to odronextamab in two patients with diffuse large B-cell lymphoma refractory to chimeric antigen receptor T-cell therapy. Br J Haematol. 2022 11; 199(3):366-370.